Pharmaceutical Technology2h
BNT-162b1 by BioNTech for Coronavirus Disease 2019 (COVID-19): Likelihood of Approval
BNT-162b1 is under clinical development by BioNTech and currently in Phase III for Coronavirus Disease 2019 (COVID-19).
Pharmaceutical Technology3h
Acasunlimab by BioNTech for Non-Small Cell Lung Cancer: Likelihood of Approval
Acasunlimab is under clinical development by BioNTech and currently in Phase III for Non-Small Cell Lung Cancer.
The Brighterside of News on MSN4h
Groundbreaking mRNA vaccine revolutionizes pancreatic cancer treatment
Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...